Increases in tumor markers are associated with primary Sjögren's syndrome-associated interstitial lung disease.
Lei ShiXiao-Lei HanHong-Xia GuoJia WangYu-Ping TangChong GaoXiao-Feng LiPublished in: Therapeutic advances in chronic disease (2020)
Tumor markers increased in serum of pSS-ILD patients. Higher CA153 levels are significantly correlated to the increased risk of ILD in patients with pSS and may be directly involved in the pathogenesis of pSS-ILD. Serum CA153 had the best diagnostic value in those tumor markers for pSS-ILD without malignancy.